Contained Micro-Dosing Xcelodose® Technology

Delivering drug directly into capsules or vials using micro-dosing technology removes the need for initial formulation development and associated stability, leading to faster first-in-man studies and cost efficiencies.

The fully programmable system ensures exceptional levels of accuracy and precision whilst minimizing wastage of drug substance. We are proud to offer multiple options of micro-dosing technology, delivering individual client volume requirements.

PCI has further invested in Xcelohood™ and Xceloprotect™ technology for the micro-dosing technologies, further enhancing our contained solutions for the development and manufacturing of highly potent drug products.

Features of Xcelodose® Technology

Our dedicated team of specialists will be happy to discuss any of your Contained Micro-Dosing Xcelodose® Technology needs. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com

Start your PCI experience today.

Rely on our contained micro-dosing Xcelodose® technology. Your drug product destination means the world to us.

talkfuture@pci.com

Spanning the cycle.A truly global proposition.

Always growing, we are driving development and connecting commercialization, and with 4300 people in 30 global GMP facilities, we are always close.